Measles antibody seropositivity among children with allergic diseases: A cross-sectional study in the Japan Environment & Children's Pilot Study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 09 01 2021
accepted: 08 09 2021
entrez: 22 9 2021
pubmed: 23 9 2021
medline: 18 11 2021
Statut: epublish

Résumé

The relationship between allergic individuals and their responsiveness to routine vaccines has rarely been investigated. This study examined whether the seroprevalence of measles antibody differed between children with and without allergic diseases in the general pediatric population. The cross-sectional study was performed within a prospective general birth cohort (a pilot study of the Japan Environment & Children's Pilot Study [JECS]) of children aged 8 years. The clinical history of allergic diseases, measles, and the concentration of measles immunoglobulin G titers in serum enzyme immunoassay were examined. Fisher's exact tests were used to assess the relationships between the allergic characteristics of the children and their measles antibody positivity rates. This study included 162 children. Any allergic disease was reported in 75 (46.3%). The measles antibody positivity rate was 94.7% among children with any allergic diseases and 92.0% among children without allergic diseases. Our results revealed no differences in measles antibody seropositivity between children with allergies and controls. Children with allergies mount and maintain a comparable immune response to the measles vaccine.

Sections du résumé

BACKGROUND
The relationship between allergic individuals and their responsiveness to routine vaccines has rarely been investigated. This study examined whether the seroprevalence of measles antibody differed between children with and without allergic diseases in the general pediatric population.
METHODS
The cross-sectional study was performed within a prospective general birth cohort (a pilot study of the Japan Environment & Children's Pilot Study [JECS]) of children aged 8 years. The clinical history of allergic diseases, measles, and the concentration of measles immunoglobulin G titers in serum enzyme immunoassay were examined. Fisher's exact tests were used to assess the relationships between the allergic characteristics of the children and their measles antibody positivity rates.
RESULTS
This study included 162 children. Any allergic disease was reported in 75 (46.3%). The measles antibody positivity rate was 94.7% among children with any allergic diseases and 92.0% among children without allergic diseases. Our results revealed no differences in measles antibody seropositivity between children with allergies and controls.
CONCLUSIONS
Children with allergies mount and maintain a comparable immune response to the measles vaccine.

Identifiants

pubmed: 34551012
doi: 10.1371/journal.pone.0257721
pii: PONE-D-21-00879
pmc: PMC8457502
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0257721

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Cytokine. 2020 Mar 6;130:155051
pubmed: 32151964
J Asthma. 2020 Apr;57(4):381-390
pubmed: 30784333
Ann Allergy Asthma Immunol. 2006 Oct;97(4):469-76
pubmed: 17069101
Vaccine. 2013 Feb 18;31(9):1293-7
pubmed: 23306371
Arch Dermatol. 2004 Dec;140(12):1513-9
pubmed: 15611432
Lancet. 1999 Jan 9;353(9147):98-102
pubmed: 10023894
BMC Public Health. 2014 Jan 10;14:25
pubmed: 24410977
J Med Virol. 2000 Dec;62(4):511-7
pubmed: 11074481
J Infect Dis. 2007 Nov 15;196(10):1433-5
pubmed: 18008219
Hum Vaccin Immunother. 2016;12(1):239-43
pubmed: 26836329
J Allergy Clin Immunol. 2004 Apr;113(4):717-24
pubmed: 15100679

Auteurs

Mayako Saito-Abe (M)

Medical Support Center for the Japan Environment and Children's Study, National Center for Child Health and Development, Tokyo, Japan.

Kiwako Yamamoto-Hanada (K)

Medical Support Center for the Japan Environment and Children's Study, National Center for Child Health and Development, Tokyo, Japan.

Kensuke Shoji (K)

Division of Infectious Diseases, National Center for Child Health and Development, Tokyo, Japan.

Miori Sato (M)

Medical Support Center for the Japan Environment and Children's Study, National Center for Child Health and Development, Tokyo, Japan.

Makoto Irahara (M)

Medical Support Center for the Japan Environment and Children's Study, National Center for Child Health and Development, Tokyo, Japan.

Yu Taniguchi (Y)

Japan Environment and Children's Study Programme Office, National Institute for Environmental Studies, Ibaraki, Japan.

Makiko Sekiyama (M)

Japan Environment and Children's Study Programme Office, National Institute for Environmental Studies, Ibaraki, Japan.

Nathan Mise (N)

Department of Environmental and Preventive Medicine, Jichi Medical University, Tochigi, Japan.

Akihiko Ikegami (A)

Department of Environmental and Preventive Medicine, Jichi Medical University, Tochigi, Japan.

Masayuki Shimono (M)

Regional Center for Pilot Study of Japan Environment and Children's Study, School of Medicine, University of Occupational and Environmental Health, Fukuoka, Japan.

Reiko Suga (R)

Regional Center for Pilot Study of Japan Environment and Children's Study, School of Medicine, University of Occupational and Environmental Health, Fukuoka, Japan.

Masafumi Sanefuji (M)

Research Center for Environment and Developmental Medical Sciences, Kyushu University, Fukuoka, Japan.
Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Shouichi Ohga (S)

Research Center for Environment and Developmental Medical Sciences, Kyushu University, Fukuoka, Japan.
Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Masako Oda (M)

Department of Public Health, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.

Hiroshi Mitsubuchi (H)

Department of Neonatology, Kumamoto University Hospital, Kumamoto, Japan.

Isao Miyairi (I)

Division of Infectious Diseases, National Center for Child Health and Development, Tokyo, Japan.

Yukihiro Ohya (Y)

Medical Support Center for the Japan Environment and Children's Study, National Center for Child Health and Development, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH